GlaxoSmithKline PLC Director/PDMR Shareholding (3061K)
13 December 2018 - 3:35AM
UK Regulatory
TIDMGSK
RNS Number : 3061K
GlaxoSmithKline PLC
12 December 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Ms E Walmsley
=== ======================== ===========================================
b) Position/status Chief Executive Officer
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ===========================================
e) Date of the transaction 2018-12-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr R G Connor
=== ======================== ===========================================
b) Position/status President, Global Vaccines
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ===========================================
e) Date of the transaction 2018-12-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr S Dingemans
=== ======================== ===========================================
b) Position/status Chief Financial Officer
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ===========================================
e) Date of the transaction 2018-12-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr N Hirons
=== ======================== ===========================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ===========================================
e) Date of the transaction 2018-12-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr L Miels
=== ======================== ===========================================
b) Position/status President, Global Pharmaceuticals
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ===========================================
e) Date of the transaction 2018-12-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mr D S Redfern
=== ======================== ============================================
b) Position/status Chief Strategy Officer
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ============================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ============================================
e) Date of the transaction 2018-12-11
=== ======================== ============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mr R Simard
=== ======================== ============================================
b) Position/status President, Pharma Supply Chain
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 9 (partnership shares)
-----------------------
GBP14.9439 9 (matching shares)
-----------------------
=== ======================== ============================================
d) Aggregated information
Aggregated volume
Price
18 Ordinary Shares
GBP14.9439
=== ======================== ============================================
e) Date of the transaction 2018-12-11
=== ======================== ============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Ms C Thomas
=== ======================== ============================================
b) Position/status SVP, Human Resources
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ============================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ============================================
e) Date of the transaction 2018-12-11
=== ======================== ============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mr P C Thomson
=== ======================== ============================================
b) Position/status President, Global Affairs
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ============================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ============================================
e) Date of the transaction 2018-12-11
=== ======================== ============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mrs V A Whyte
=== ======================== ===========================================
b) Position/status Company Secretary
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP14.9439 8 (partnership shares)
-----------------------
GBP14.9439 8 (matching shares)
-----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP14.9439
=== ======================== ===========================================
e) Date of the transaction 2018-12-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHQLLFFVLFXFBZ
(END) Dow Jones Newswires
December 12, 2018 11:35 ET (16:35 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024